Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Thyroid & Endocrine Cancers

Mingzhao Xing

邢明照

MD, PhD

🏢Johns Hopkins University School of Medicine(约翰斯·霍普金斯大学医学院)🌐USA

Professor of Medicine, Oncology, and Pathology; Director, Laboratory for Cellular and Molecular Thyroid Research医学、肿瘤学与病理学教授;甲状腺细胞与分子研究实验室主任

76
h-index
2
Key Papers
4
Awards
2
Key Contributions

👥Biography 个人简介

Dr. Mingzhao Xing is a world-leading authority on the molecular genetics of thyroid cancer at Johns Hopkins. He discovered and defined the clinical significance of BRAF V600E mutation and TERT promoter mutations in thyroid cancer, transforming molecular diagnostics and prognostic stratification of thyroid malignancies.

Share:

🧪Research Fields 研究领域

Thyroid Cancer Molecular Diagnostics甲状腺癌分子诊断
BRAF MutationBRAF突变
TERT Promoter MutationsTERT启动子突变
Genetic Risk Stratification遗传风险分层
Oncogenic Signaling致癌信号通路

🎓Key Contributions 主要贡献

BRAF V600E in Thyroid Cancer

Pioneered investigation of BRAF V600E mutation as the most common genetic alteration in papillary thyroid cancer, demonstrating its association with aggressive clinicopathologic features and its value as a diagnostic and prognostic biomarker.

TERT Promoter Mutations

Identified and characterized TERT promoter mutations in thyroid cancer, showing their synergy with BRAF mutations to predict highest-risk disease and mortality, fundamentally changing molecular risk stratification for thyroid cancer patients.

Representative Works 代表性著作

[1]

BRAF mutation in papillary thyroid carcinoma

Journal of the National Cancer Institute (2003)

Seminal study identifying BRAF V600E as the most common mutation in papillary thyroid cancer, establishing its role as a key oncogenic driver and diagnostic marker.

[2]

TERT promoter mutations and their association with BRAF V600E mutation and aggressive thyroid cancer

Journal of Clinical Endocrinology & Metabolism (2014)

Landmark study revealing synergistic effect of co-occurring TERT and BRAF mutations in predicting thyroid cancer mortality, redefining molecular risk stratification.

🏆Awards & Recognition 奖项与荣誉

🏆American Thyroid Association Presidential Award
🏆Endocrine Society William Bremner Award
🏆Johns Hopkins Discovery Award
🏆NIH Merit Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 邢明照 的研究动态

Follow Mingzhao Xing's research updates

留下邮箱,当我们发布与 Mingzhao Xing(Johns Hopkins University School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment